TP53 and cancer: PRMT6 and H3R2me2a bind to the promoter regions of p53 in MEF, with subsequent activation of p21 but not PAI-158; it may also directly bind to p21 in a p53-independent way in various cancer cells to negatively regulate the transcription59,60.